Protective immunity elicited by ultraviolet-irradiated third-stage infective hookworm (Necator americanus and Ancylostoma caninum) larvae in mice and hamsters
- PMID: 17333729
Protective immunity elicited by ultraviolet-irradiated third-stage infective hookworm (Necator americanus and Ancylostoma caninum) larvae in mice and hamsters
Abstract
The protective immunity elicited by ultraviolet-irradiated third-stage infective larvae of Necator americanus (UV-NaL3) and Ancylostoma caninum (UV-AcL3) was evaluated in laboratory mice (a non-permissive model) and hamsters (a permissive model). After optimizing the time of exposure to UV-irradiation, both oral and subcutaneous vaccination routes with UV-AcL3 in mice were explored. Oral vaccination was more effective at reducing the number of challenge AcL3 entering the lungs, whereas subcutaneous vaccination was more effective at blocking muscle entry. When UV-irradiated NaL3 and non-irradiated AcL3 were used as vaccines in hamsters, both of them were effective at reducing adult hookworm burdens. However, the length of protection afforded by UV-irradiated L3 was substantially greater than that resulting from immunization with non-irradiated L3. A single dose was less effective than multiple doses. The protective immunity elicited by UV-irradiated NaL3 given once every other week for a total of three immunizations was similar to that elicited by non-irradiated AcL3 given during the same schedule. Protection was not significantly affected by administering the L3 on a weekly basis for a total of three immunizations, even though the antibody titers were reduced using this schedule. These studies will facilitate the elucidation of the mechanisms underlying larval protection.
Similar articles
-
Protective immunity in mice elicited by living infective third-stage hookworm larvae (Shanghai strain of Ancylostoma caninum).Chin Med J (Engl). 1998 Jan;111(1):43-8. Chin Med J (Engl). 1998. PMID: 10322652
-
The evaluation of recombinant hookworm antigens as vaccines in hamsters (Mesocricetus auratus) challenged with human hookworm, Necator americanus.Exp Parasitol. 2008 Jan;118(1):32-40. doi: 10.1016/j.exppara.2007.05.010. Epub 2007 Jun 6. Exp Parasitol. 2008. PMID: 17645877
-
Cutaneous and subcutaneous mast cell and eosinophil responses after challenge in mice vaccinated with living infective third-stage hookworm larvae.Chin Med J (Engl). 1999 Nov;112(11):1020-3. Chin Med J (Engl). 1999. PMID: 11721464
-
Immunobiology of hookworm infection.FEMS Immunol Med Microbiol. 2005 Feb 1;43(2):115-24. doi: 10.1016/j.femsim.2004.11.006. FEMS Immunol Med Microbiol. 2005. PMID: 15681140 Review.
-
The immunoepidemiology of human hookworm infection.Parasite Immunol. 2004 Nov-Dec;26(11-12):443-54. doi: 10.1111/j.0141-9838.2004.00727.x. Parasite Immunol. 2004. PMID: 15771680 Review.
Cited by
-
Promising Technologies in the Field of Helminth Vaccines.Front Immunol. 2021 Aug 19;12:711650. doi: 10.3389/fimmu.2021.711650. eCollection 2021. Front Immunol. 2021. PMID: 34489961 Free PMC article. Review.
-
Attenuation Effect of UV on Haemonchus contortus Larvae in Experimentally Infected Goats.Iran J Parasitol. 2013 Oct;8(4):559-69. Iran J Parasitol. 2013. PMID: 25516737 Free PMC article.
-
Vaccination of human participants with attenuated Necator americanus hookworm larvae and human challenge in Australia: a dose-finding study and randomised, placebo-controlled, phase 1 trial.Lancet Infect Dis. 2021 Dec;21(12):1725-1736. doi: 10.1016/S1473-3099(21)00153-5. Epub 2021 Aug 19. Lancet Infect Dis. 2021. PMID: 34419209 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Medical